Vesencumab
- Generic Name
- Vesencumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1205533-60-3
- Unique Ingredient Identifier
- 7SF22186WT
- Background
Vesencumab is under investigation in clinical trial NCT00747734 (A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00954642
A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
Completed
- Conditions
- First Posted Date
- 2008-09-05
- Last Posted Date
- 2011-04-20
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT00747734
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath